TCI Wealth Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
DM
RP
AAM
TCI Wealth Advisors's AMED Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Amedisys (AMED) in Q2 2023, closing a stake of 54 shares — an estimated $3.97K sold.
TCI Wealth Advisors first reported a position in AMED in Q1 2016 and held it in 29 quarters. The position peaked at $24K in Q1 2021. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.
- TCI Wealth Advisors reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 54 Amedisys shares in Q2 2023, an estimated $3.97K.
- TCI Wealth Advisors first reported a position in Amedisys in Q1 2016 and held it in 29 quarters.
- TCI Wealth Advisors's Amedisys position peaked at $24K in Q1 2021.
- 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.